Lupin launches generic version of Pfizer's antibiotic in the US
New Delhi: Pharma major Lupin said it has launched Doxycycline Hyclate Tablet USP, 100 mg in the US market, used for the treatment of infections and acne.
The company announced launch of its Doxycycline Hyclate Tablet USP, 100 mg having received an approval from the United States Food and Drug Administration (FDA) earlier, Lupin said in a regulatory filing.
The company's drug is the AB-rated generic equivalent of Pfizer's Vibra-Tabs, 100 mg, it added.
The drug is used in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd